Gates Foundation backs Basel’s Axmed with €5 million to support affordable medicines distribution

February 17, 2026 at 03:34 PM UTC
EU-Startups
Original: EN
Gates Foundation backs Basel’s Axmed with €5 million to support affordable medicines distribution

The European HealthTech sector is witnessing significant investment focused on digital infrastructure and efficient delivery of medical supplies. Swiss company Axmed recently secured a substantial €5 million non-dilutive grant from the Gates Foundation, earmarked for enhancing the distribution of affordable medicines in low- and middle-income countries. This funding highlights a growing emphasis on technology-driven solutions to address critical healthcare access challenges globally. Axmed's platform operates as a business-to-business procurement and integrated logistics system. It leverages pooled demand, data-driven sourcing, and coordinated international shipping to reduce costs by an estimated 30-35% for its clients. In 2025, Axmed facilitated the delivery of over 1,800 metric tonnes of healthcare products, impacting more than 4.2 million patients, demonstrating its scalable impact and efficient operational model. This investment in Axmed aligns with a broader trend of capital flowing into healthcare logistics and digital care across Europe. Competitors like Germany's Qrago, which digitizes healthcare logistics, and UK-based Wanda Health, focusing on virtual care, have also recently attracted significant funding. These developments collectively underscore investor confidence in HealthTech's ability to improve healthcare system efficiency and broaden patient reach through digital innovation.

Curated and translated by Europe Digital for our multilingual European audience.

Source Information

Publication: EU-Startups
Published: February 17, 2026 at 03:34 PM UTC
All rights remain with the original publisher.